SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001962918-23-000009
Filing Date
2023-06-15
Accepted
2023-06-15 16:22:28
Documents
13
Period of Report
2023-06-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K slrn-20230615.htm   iXBRL 8-K 38594
2 EX-99.1 slrn-20230615xexx991.htm EX-99.1 46705
  Complete submission text file 0001962918-23-000009.txt   234186

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20230615.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20230615_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20230615_pre.xml EX-101.PRE 13037
7 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20230615_htm.xml XML 11734
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 231017653
SIC: 2834 Pharmaceutical Preparations